Quest Diagnostics Inc. http://www.alacrastore.com/company-snapshot/Quest_Diagnostics_Inc-1031217 Saturday, July 19, 2008 1:04:10 AM 1031217 Quest Diagnostics Inc. en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/newstex/PRN-0005-26574339newstex/PRN-0005-26574339xml MADISON, N.J., Jul. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, announced today that its second-quarter...04000000040060000400600504016000040160487/10/2008 1:22:24 PM180000001800400018008000PR Newswire USPRN-0005-26574339QUEST DIAGNOSTICS INCDGXNewsNewstexhttp://www.alacrastore.com/storecontent/spcred/657706spcred/657706normThe latest News from S&Pglobal7/2/2008 6:24:47 PM100News657706United StatesHealth Care ServicesUnited StatesGlobal IssuersCorporationsHealth CareNewsBOSTON (Standard&Poor's) July 2, 2008--Standard&Poor's Ratings Services said today that it revised its outlook on Madison, N.J.-based Quest Diagnostics Inc. to stable from negative. The outlook revision reflects the improvements in the company's financial risk profile since its completion of the $2 billion acquisition of AmeriPath Group Holdings Inc. on May 31, 2007; we expect Quest will continue to improve its financial risk profile throughout 2008. The outlook revision also reflects the reduced risk of integration surprises from AmeriPath, given that the acquisition is more than one year old. The 'BBB+' corporate rating is affirmed. "Our ratings on Quest continue to reflect the company's No. 1 position in the U.S. market for diagnostic testing services, itsUSA74834L35102015 351020 3510 35Quest Diagnostics Inc.308908USADGXNEWSGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/657707spcred/657707normThe latest Research Update from S&Pglobal7/2/2008 6:24:47 PM175Research Update657707United StatesHealth Care ServicesUnited StatesGlobal IssuersCorporationsHealth CareResearch UpdateOn July 2, 2008, Standard&Poor's Ratings Services revised its outlook on Madison, N.J.-based Quest Diagnostics Inc. to stable from negative. The outlook revision reflects the improvements in the company's financial risk profile since its completion of the $2 billion acquisition of AmeriPath Group Holdings Inc. on May 31, 2007; we expect Quest will continue to improve its financial risk profile throughout 2008. The outlook revision also reflects the reduced risk of integration surprises from AmeriPath, given that the acquisition is more than one year old. The 'BBB+' corporate credit rating is affirmed. Our ratings on Quest continue to reflect the company's No. 1 position in the U.S. market for diagnostic testing services, its history of successful acquisitions andUSA74834L35102015 351020 3510 35Quest Diagnostics Inc.308908USADGXRESUPDGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-26327788newstex/PRN-0005-26327788xml Denmark, Jun. ##, #### (PRNewswire-FirstCall delivered by Newstex) -- Cynthia K. French joins Exiqon from Affymetrix where she served as Vice President, Clinical Services Laboratory and was responsible for building and operating the...0400000004002000040020066/30/2008 5:18:52 AM18000000180070001802000019000000190020001900200719002018PR Newswire USPRN-0005-26327788AFFYMETRIX INCBIO RAD LABORATORIES INCQUEST DIAGNOSTICS INCAFFXBIODGXNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1830241ccbn/T1830241norm... - Jefferies & Company - AnalystOkay. Next speaker is Quest Diagnostics. It is the other large clinical laboratory provider in the United States. I am pleased to have Bob Hagemann, Chief Financial Officer, here and Laure Park, SVP of Investor Relations. Did I just promote you? Anyway, Bob, take it away. Thanks for coming. Glad to have you. ... 6/24/2008 2:04:00 PMQuest Diagnostics54.0000FinalQuest Diagnostics at Jefferies & Co. Annual Healthcare Conference TranscriptDGX9:00am ETTranscriptT1830241Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-25614276newstex/PRN-0005-25614276xml May ##, #### (PR Newswire delivered by Newstex) -- HARBIN, China and NEW YORK, May ## /Xinhua-PRNewswire-FirstCall/ -- China North East Petroleum Holdings Limited (the ''Company'') (OTC: CNEH), an oil producing company in Northern China,...090000000901500004000000040160000401600804005000040050120600000006001000060010025/29/2008 9:25:45 AM18000000180070001900000019002000190020091900201319002004PR Newswire USPRN-0005-25614276CHINA NORTH EAST PETROLEUM HOLDINGS LTDIMMUCELL CORPPAYCHEX INCQUEST DIAGNOSTICS INCRobert C BruceCNEHDGXICCCPAYXNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1827582ccbn/T1827582norm...Good morning. I'm Surya Mohapatra, Chairman and Chief Executive Officer of Quest Diagnostics, and it is my privilege to welcome you, and those listening via the Internet, to our Annual Shareholders Meeting. We are pleased that you are here. The meeting is now called to order. Bill O'Shaughnessy, who is Assistant General Counsel and Corporate Secretary of the Company, will act as Secretary of this meeting. I would now like to introduce to you the directors of the Company who are present here, Dr. Jenne Britell, Chairman and Chief Executive Officer of Structured Ventures. Bill Buehler, Retired Vice Chairman of Xerox Corporation, Rosanne Haggerty, Founder and President of Common Ground, Gary Pfeiffer, Retired Senior Vice President and Chief Financial Officer of DuPont, Dr. Dan Stanzione, President and Emeritus of Bell Laboratories, Dr. Gail Wilensky, Senior Fellow of Project HOPE, Jack Ziegler, Retired President of Worldwide Consumer Health at GlaxoSmithKline. Our agenda for today is in the... 5/19/2008 10:05:00 AMQuest Diagnostics54.0000FinalQuest Diagnostics Shareholders Meeting TranscriptDGX10:30am ETTranscriptT1827582Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-25298443newstex/PRN-0005-25298443xml FREMONT, Calif., May ##, May ##, #### (PR Newswire delivered by Newstex) -- FREMONT, Calif., May ## /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML), a molecular diagnostics company, today announced financial results for the...040000000401600004016001040160180401604704016008040160030400200004002006070000000700100007001004070140000701400707014008070140050701400907003000070030045/15/2008 10:26:38 AM180000001800400018020000180120001800700018006000190000001900100019001041PR Newswire USPRN-0005-25298443QUEST DIAGNOSTICS INCVERMILLION INC.GAIL S PAGEDGXVRMLNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-25124055newstex/PRN-0005-25124055xml MADISON, N.J., May #, May #, #### (PR Newswire delivered by Newstex) -- MADISON, N.J., May # /PRNewswire-FirstCall/ -- Enterix Inc., a wholly-owned subsidiary of Quest Diagnostics Incorporated (NYSE: DGX), today announced the availability...07000000070010000700100407014000070140080700300007003007070030040400000004006000040060050100000001005000010050011300000013001000130010025/8/2008 12:17:30 PM180000001801600018020000190000001900100019002000190020181900200719002014PR Newswire USPRN-0005-25124055I T LIMITEDQUEST DIAGNOSTICS INCDGXILIMFNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/HUG-0001-25033660newstex/HUG-0001-25033660xml May #, #### (Hugin AS delivered by Newstex) -- Key Figures - Revenue: EUR #.# million in Q# ####, up by ##% (Q# ####: EUR #.# million) - EBIT: EUR -#.# million in Q# ####, improved by ##% (Q# ####: EUR -#.# million) - Net loss: EUR...07000000070010000700100407014000070140080701401207003000070030040700300704000000040160000401604804016013040160010401601804002000040020010400600004006005130000001300200013002005130100001301000513001000130010020100000001005000010050015/6/2008 9:37:37 AM18000000180200001802200018008000180150001800400019000000190020001900201819002007Hugin ASHUG-0001-25033660JOHNSON & JOHNSONPFIZER INCQUEST DIAGNOSTICS INCDGXJNJPFENewsNewstexhttp://www.alacrastore.com/storecontent/newstex/BW-0001-24842379newstex/BW-0001-24842379xml PRINCETON, N.J., Apr. ##, #### (Business Wire) -- BullMarket.com (http://www.bullmarket.com), an online investment newsletter focused on long-term growth and income-generating stocks, announced today that it has provided subscribers...04000000040060000400600504016000040160184/28/2008 11:16:33 AM180000001800800018004000190000001900200019002007Business WireBW-0001-24842379AETNA INCPHILIP MORRIS INTERNATIONAL INC.QUEST DIAGNOSTICS INCAEFAETDGXPMNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/B1795727ccbn/B1795727norm...DGX reported #Q## revenues of $#.#b and diluted EPS from continuing operations of $#.##. Expects #### diluted EPS, excluding any potential special charges, to be $#.##-#.##. www.streetevents.comContact Us ... 4/21/2008 12:04:00 PMQuest Diagnostics54.0000EditedQ1 2008 Quest Diagnostics Earnings Conference Call SummaryDGX8:30am ETBriefB1795727Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1795727ccbn/T1795727norm... - Quest Diagnostics - VP - IR Thank you, and good morning. I am here with Surya Mohopatra, our Chairman and Chief Executive Officer, and Bob Hagemann, our Chief Financial Officer. Some of our commentary and answers to questions may contain forward-looking statements. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date that they are made, and which reflect management's current estimates, projections, expectations, or beliefs, which involve risks and uncertainties that could cause actual results and outcomes to be materially different. Risks and uncertainties that may affect the future results of the company include but are not limited to, adverse results from pending or future government investigations, lawsuits, or private actions, the competitive environment, changes in government regulations, changes in relationships with customers, payors, suppliers, and strategic partners, and other factors described in the Quest Diagnostics... 4/21/2008 10:04:00 AMQuest Diagnostics54.0000FinalQ1 2008 Quest Diagnostics Earnings Conference Call TranscriptDGX8:30am ETTranscriptT1795727Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/newstex/PRN-0005-24646944newstex/PRN-0005-24646944xml MADISON, N.J., April ##, Apr. ##, #### (PR Newswire delivered by Newstex) -- MADISON, N.J., April ## /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information...04000000040190000401600004016048040160010401600304016018040160190401605204006000040060054/21/2008 8:15:07 AM180000001800800018004000180130001801600018012000PR Newswire USPRN-0005-24646944QUEST DIAGNOSTICS INCSURYA N MOHAPATRADGXNewsNewstexhttp://www.alacrastore.com/storecontent/newstex/PRN-0005-24315503newstex/PRN-0005-24315503xml MADISON, N.J., April #, ####, Apr. #, #### (PR Newswire delivered by Newstex) -- MADISON, N.J., April #, #### /PRNewswire/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information...0400000004006000040060050401600004016048180000001800800018004000PR Newswire US4/7/2008 10:18:15 AMPRN-0005-24315503QUEST DIAGNOSTICS INCDGXNewsNewstexhttp://www.alacrastore.com/storecontent/spcred/640351spcred/640351normThe latest Full Report from S&P4/1/2008 1:19:36 PMFull Report400global640351United StatesHealth Care ServicesUnited StatesGlobal IssuersCorporationsHealth CareFull ReportNo. 1 position in the U.S. market for diagnostic testing services; Strong cash flow generation; and Improving capital structure. Narrow business focus; Acquisitive growth strategy; Competition for contracts; and Potential for price reductions for the company's services. The rating on Madison, N.J.-based Quest Diagnostics Inc. continues to reflect the company's No. 1 position in the U.S. market for diagnostic testing services and its strong cash flow generation. These factors are somewhat offset by the company's acquisitive growth strategy, narrow business focus, competition for contracts, and the potential for price reductions for the company's services. Quest attained its leading position primarily by purchasing rivals. Indeed, the successful integration of these acquisitions and the company's internal operating improvements enabled Quest to increaseUSA74834L35102015 351020 3510 35Quest Diagnostics Inc.308908USADGXFULLGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/spcred/640352spcred/640352normThe latest Summary from S&P4/1/2008 1:19:36 PMSummary175global640352United StatesHealth Care ServicesUnited StatesGlobal IssuersCorporationsHealth CareSummaryThe rating on Madison, N.J.-based Quest Diagnostics Inc. continues to reflect the company's No. 1 position in the U.S. market for diagnostic testing services and its strong cash flow generation. These factors are somewhat offset by the company's acquisitive growth strategy, narrow business focus, competition for contracts, and the potential for price reductions for the company's services. Quest attained its leading position primarily by purchasing rivals. Indeed, the successful integration of these acquisitions and the company's internal operating improvements enabled Quest to increase scale and ultimately EBITDA margins. Standard&Poor's Ratings Services expects this to continue as Quest introduces higher-margin tests and implements internal process improvements. Quest's loss of its contract with UnitedHealthcare placed downward pressure on the company'sUSA74834L35102015 351020 3510 35Quest Diagnostics Inc.308908USADGXSUMMARYGLOBISSCORPHealthCredit & Investment ResearchS&P Credit Researchhttp://www.alacrastore.com/storecontent/newstex/HUG-0001-24128083newstex/HUG-0001-24128083xml Mar. ##, #### (Hugin AS delivered by Newstex) -- Successful execution on corporate strategy - Financial and strategic framework set for the future Financials in line with latest expectations: - Full year revenue EUR #.# million -...010000000102100009000000090050000700000007001000070010040701400007014008070140120700300007003004070030070400000004016000040160480401601304016001040160180400200004002001130000001300200013002005130100001301000501005000010050010200000002002000020020081800000018008000180150001802000018022000180040001801800019000000190020001900201819002007Hugin AS3/31/2008 3:20:08 AMHUG-0001-24128083JOHNSON & JOHNSONMERCK & CO INCMYRIAD GENETICS INCQUEST DIAGNOSTICS INCDGXJNJMRKMYGNNewsNewstexhttp://www.alacrastore.com/storecontent/ccbn/T1779746ccbn/T1779746norm... - Lehman Brothers - AnalystOkay why don't we get started here? It's a great pleasure for me to kick off day two of the healthcare conference with Quest Diagnostics. Quest is the largest provider of clinical lab services. This has been a real focused (inaudible) press for the last several years. It's a great pleasure to have the company joining us here today. From the company, we have Bob Hagemann, the company's CFO, and we have Laure Park, the company's Director of IR here also. We have a ##-minute presentation. And we'll have a breakout session following the presentation in the Crown Conch Room. So with that, let me turn it over to Bob. ... 3/19/2008 12:06:00 PMQuest Diagnostics54.0000FinalQuest Diagnostics at Lehman Brothers Healthcare Conference TranscriptDGX9:00am ETTranscriptT1779746Credit & Investment ResearchThomson Street Eventshttp://www.alacrastore.com/storecontent/ccbn/T1778380ccbn/T1778380norm... - Cowen & Co. - AnalystOkay, good, thank you. Hi, good morning everybody, to those of you in the room and those listening on the webcast, welcome to the Quest Diagnostics Workshop at our ##th Annual Healthcare Conference. I am Kemp Dolliver, the healthcare services analyst for Cowen & Co. And our primary speaker today is Laurie Park, who manages Investor Relations for Quest Diagnostics. She is also joined by her colleague, [Bob O'Keefe]. Laurie will run through the presentation here. If there is time left over, there will a Q&A and the breakout session for those of you here will be around the corner in the Tufts Room. So, with that, Laurie thanks for joining us and this is Quest Diagnostics. ... 3/18/2008 2:06:00 PMQuest Diagnostics54.0000FinalQuest Diagnostics at Cowen and Company Health Care Conference TranscriptDGX8:45am ETTranscriptT1778380Credit & Investment ResearchThomson Street Events